PANRETIN Trademark

Trademark Overview

On Wednesday, July 12, 1995, a trademark application was filed for PANRETIN with the United States Patent and Trademark Office. The USPTO has given the PANRETIN trademark a serial number of 74700355. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, October 4, 2018. This trademark is owned by LIGAND PHARMACEUTICALS INC.. The PANRETIN trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations, namely retinoids, for the treatment of skin related diseases, disorders of the eye, cancer and precancerous conditions, cardiovascular disorders, inflammatory diseases, neuro-degenerative diseases, and disorders related to the modulation of apoptosis
panretin

General Information

Serial Number74700355
Word MarkPANRETIN
Filing DateWednesday, July 12, 1995
Status800 - REGISTERED AND RENEWED
Status DateThursday, October 4, 2018
Registration Number2149627
Registration DateTuesday, April 7, 1998
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 26, 1996

Trademark Statements

Goods and Servicespharmaceutical preparations, namely retinoids, for the treatment of skin related diseases, disorders of the eye, cancer and precancerous conditions, cardiovascular disorders, inflammatory diseases, neuro-degenerative diseases, and disorders related to the modulation of apoptosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 17, 1995
Primary Code005
First Use Anywhere DateFriday, May 9, 1997
First Use In Commerce DateFriday, May 9, 1997

Trademark Owner History

Party NameMERCURY PHARMA GROUP LIMITED
Party Type33 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLONDON EC2M1QS
GB
Party NameCONCORDIA PHARMACEUTICALS INC.
Party Type32 - New Owner After Registration
Legal Entity Type78 - NOT AVAILABLE
AddressLUXEMBOURG L-1610
LU
Party NameEISAI INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNutley, NJ 07110
Party NameLIGAND PHARMACEUTICALS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameLIGAND PHARMACEUTICALS INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameLIGAND PHARMACEUTICALS INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, September 20, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 4, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, October 4, 2018REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, October 4, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, October 3, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 27, 2018TEAS SECTION 8 & 9 RECEIVED
Friday, April 7, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, April 17, 2008REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, April 17, 2008REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, April 3, 2008ASSIGNED TO PARALEGAL
Wednesday, March 26, 2008TEAS SECTION 8 & 9 RECEIVED
Wednesday, March 26, 2008AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 22, 2007CASE FILE IN TICRS
Monday, October 18, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 17, 2004REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, December 12, 2003REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, June 25, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 2, 2003PAPER RECEIVED
Tuesday, April 7, 1998REGISTERED-PRINCIPAL REGISTER
Thursday, February 12, 1998ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 12, 1998ASSIGNED TO EXAMINER
Monday, February 9, 1998STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 16, 1997USE AMENDMENT FILED
Friday, July 11, 1997SOU EXTENSION 2 GRANTED
Tuesday, June 17, 1997SOU EXTENSION 2 FILED
Saturday, January 25, 1997SOU EXTENSION 1 GRANTED
Tuesday, December 10, 1996SOU EXTENSION 1 FILED
Tuesday, June 18, 1996NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 26, 1996PUBLISHED FOR OPPOSITION
Friday, February 23, 1996NOTICE OF PUBLICATION
Wednesday, January 24, 1996APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 18, 1996EXAMINER'S AMENDMENT MAILED
Friday, December 22, 1995ASSIGNED TO EXAMINER
Friday, December 22, 1995ASSIGNED TO EXAMINER

Related Keywords

panretin diseases disorders related neuro cardiovascular inflammatory degenerative apoptosis modulation conditions